ArticleFrontiers in cardiovascular medicine2025
Correlation between visceral fat area and cardiac valve calcification in hemodialysis patients.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of risk factors and construction of nomogram model for cardiac valve calcification of patients undergoing hemodialysis.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the relationship between Visceral Fat Area (VFA) and cardiac valve calcification (CVC) in Maintenance Hemodialysis (MHD) patients. Methods: This cross-sectional study included MHD patients enrolled at our hospital between July 2023 and February 2024. Body composition analysis was performed on recruited patients. According to echocardiography results, the participants were classified into 2 groups. We then compared their clinical characteristics and identified independent factors influencing CVC through multivariate logistic regression. The ROC curve was employed to assess the ability of influencing factors to predict CVC in MHD patients. Results: There are 154 MHD patients were recruited, including 76 with CVC and 78 without CVC. Significant differences were observed between CVC and non-CVC participants in age, the proportion of diabetic nephropathy, the proportion of diabetes mellitus, the levels of Hs-CRP, fasting blood glucose, blood phosphorus, iPTH, HDL-C and VFA ( Conclusions: For MHD patients, increased VFA may serve as a potential marker for detecting CVC and can assist in clinical decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.